NCT00003780View on ClinicalTrials.gov

Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of the Pancreas

PHASE2UnknownINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

December 31, 1998

Conditions
Pancreatic Cancer
Interventions
BIOLOGICAL

tumor infiltrating lymphocyte therapy

DRUG

gemcitabine hydrochloride

Trial Locations (1)

92614

Meyer Pharmaceuticals, LLC, Irvine

Sponsors
All Listed Sponsors
lead

Meyer Pharmaceuticals

INDUSTRY

NCT00003780 - Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of the Pancreas | Biotech Hunter | Biotech Hunter